The Improved Experience You’ve Been Waiting For! Discover the refreshed menu, enjoy the custom dashboard, and make use of the powerful stock screener to enhance your investment approach. Explore Now

BOHIX CollegeAdvantage 529 Savings Plan - BlackRock High Yield Bond Option

USD 26.44 -0.04 ( -0.151057)
Icon

CollegeAdvantage 529 Savings Plan - BlackRock High Yield Bond Option (BOHIX) Stock Analysis and Price Targets

FUND | Others | NMF
Target Add to Watchlist
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 26.44

-0.04 (-0.15)%

N/A

N/A

USD -1.00

N/A
Icon

BOHIX

CollegeAdvantage 529 Savings Plan - BlackRock High Yield Bond Option (USD)
FUND | NMF
USD 26.44
-0.04 ( -0.151057)
Watchlist

CollegeAdvantage 529 Savings Plan - BlackRock High Yield Bond Option (BOHIX) Stock Forecast

USD -1.00

Based on the CollegeAdvantage 529 Savings Plan - BlackRock High Yield Bond Option stock forecast from 0 analysts, the average analyst target price for CollegeAdvantage 529 Savings Plan - BlackRock High Yield Bond Option is not available over the next 12 months. CollegeAdvantage 529 Savings Plan - BlackRock High Yield Bond Option’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of CollegeAdvantage 529 Savings Plan - BlackRock High Yield Bond Option is Neutral, which is based on 0 positive signals and 0 negative signals. At the last closing, CollegeAdvantage 529 Savings Plan - BlackRock High Yield Bond Option’s stock price was USD 26.44. CollegeAdvantage 529 Savings Plan - BlackRock High Yield Bond Option’s stock price has changed by +0.08% over the past week, +1.65% over the past month and +13.48% over the last year.

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date
Stock Target Advisor

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like